Arbor Rapha Capital Bioholdings Corp. I (ARCK) Financial Statements (2024 and earlier)

Company Profile

Business Address 333 EARLE OVINGTON BLVD., SUITE 900
UNIONDALE, NY 11553
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 677 - Blank Checks (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments952,4391,065,4741,344,116250
Cash and cash equivalents952,4391,065,4741,344,116250
Prepaid expense392,905398,279406,500 
Total current assets:1,345,3441,463,7531,750,616250
Noncurrent Assets
Prepaid expense131,189227,973324,753 
Asset, held-in-trust177,071,988176,830,305176,815,422 
Deferred costs    402,090
Total noncurrent assets:177,203,177177,058,278177,140,175402,090
TOTAL ASSETS:178,548,521178,522,031178,890,791402,340
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Other undisclosed current liabilities490,136374,561297,705 
Total current liabilities:490,136374,561297,705 
Noncurrent Liabilities
Liabilities, other than long-term debt4,312,5004,312,5004,312,50067,340
Due to related parties4,312,5004,312,5004,312,50067,340
Other undisclosed noncurrent liabilities6,037,5006,037,5006,037,500 
Total noncurrent liabilities:10,350,00010,350,00010,350,00067,340
Other undisclosed liabilities    310,234
Total liabilities:10,840,13610,724,56110,647,705377,574
Temporary equity, carrying amount 176,812,500176,812,500176,812,500 
Equity
Equity, attributable to parent, including:(9,104,115)(9,015,030)(8,569,414)24,766
Additional paid in capital    24,569
Accumulated deficit(9,104,546)(9,015,461)(8,569,845)(234)
Other undisclosed equity, attributable to parent431431431431
Other undisclosed equity    
Total equity:(9,104,115)(9,015,030)(8,569,414)24,766
TOTAL LIABILITIES AND EQUITY:178,548,521178,522,031178,890,791402,340

Income Statement (P&L) (USD)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
Operating expenses(330,768)(460,499)  
Operating loss:(330,768)(460,499)  
Nonoperating income241,68314,833  
Investment income, nonoperating241,68314,883  
Income (loss) from continuing operations before income taxes:(89,085)(445,666)  
Income tax expense    
Income (loss) from continuing operations:(89,085)(445,666)  
Income (loss) before gain (loss) on sale of properties:(89,085)(445,666)
Other undisclosed net income  891,282  
Net income (loss):(89,085)445,616  
Other undisclosed net loss attributable to parent  (891,232)  
Net income (loss) available to common stockholders, diluted:(89,085)(445,616)  

Comprehensive Income (USD)

9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
12/31/2021
Q4
9/30/2021
Q3
Net income (loss):(89,085)445,616  
Comprehensive income (loss), net of tax, attributable to parent:(89,085)445,616  

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: